TJ

Tejas Jagdishbhai Kundaria

Active Director Designated Partner DIN 09404801
DIN 09404801 First appointment Nov 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Tejas Jagdishbhai Kundaria

Data last updated:

Tejas Jagdishbhai Kundaria is a Designated Partner at Chronicare Pharmaceuticals Llp (since 2021). The company operates in Chemicals.

DIN 09404801
Primary Designation Designated Partner
Industry Chemicals
First Appointment 18 Nov 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner18 Nov 20212021Active

Board colleagues of Tejas Jagdishbhai Kundaria

NameDINCompanyDesignation
Prashant Amrutlal Aghera09404800Chronicare Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Chronicare Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Tejas Jagdishbhai Kundaria

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tejas Jagdishbhai Kundaria

Tejas Jagdishbhai Kundaria currently holds 1 directorship: Chronicare Pharmaceuticals Llp (Designated Partner, since 18 Nov 2021).

Tejas Jagdishbhai Kundaria was first appointed on 18 Nov 2021 as Designated Partner at Chronicare Pharmaceuticals Llp.

The current boards of Tejas Jagdishbhai Kundaria's companies include Prashant Amrutlal Aghera (Chronicare Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available